Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells

Autor: Mario Calvitti, Claudia Volpi, Sonia-Maria Poli, Madeleine Heroux, Giada Mondanelli, Maria Laura Belladonna, Silvio Bicciato, Francesca Fallarino, Alberta Iacono, Aldo Solari, Isabelle Royer-Urios, Marco Gargaro, Cinzia Antognelli, Carmine Vacca, Céline Mordant, Mathias Cacquevel, Maria Teresa Pallotta, Paolo Puccetti, Sylvain Celanire, Ursula Grohmann, Roberta Bianchi, Ciriana Orabona, Pierre-Alain Vitte, Manfred Schneider, Elisa Albini, Laurent Galibert
Přispěvatelé: Volpi, C, Mondanelli, G, Pallotta, M, Vacca, C, Iacono, A, Gargaro, M, Albini, E, Bianchi, R, Belladonna, M, Celanire, S, Mordant, C, Heroux, M, Royer Urios, I, Schneider, M, Vitte, P, Cacquevel, M, Galibert, L, Poli, S, Solari, A, Bicciato, S, Calvitti, M, Antognelli, C, Puccetti, P, Orabona, C, Fallarino, F, Grohmann, U
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Autoimmunity
Receptors
Metabotropic Glutamate

PI3K
phosphatidylinositol-3-kinase

Dendritic cells
PI3K
Immune regulation
Indoleamine 2 3-dioxygenase 1
mGluR4
Neuroinflammation
Noncanonical GPCR signaling
Src kinase
Tryptophan metabolism
Cellular and Molecular Neuroscience
Pharmacology
Mice
Phosphatidylinositol 3-Kinases
RNA
Small Interfering

Metabotropic glutamate receptor 4
Experimental autoimmune encephalomyelitis
DC
Dendritic cell

3. Good health
Cell biology
PAM
positive allosteric modulator

Treg
T regulatory

IDO1
indoleamine 2
3-dioxygenase 1

Female
Signal transduction
Dendritic cell
Signal Transduction
Allosteric modulator
Allosteric regulation
Indoleamine 2
3-dioxygenase 1

Biology
Pertussis toxin
Article
03 medical and health sciences
Allosteric Regulation
RR-EAE
relapsing-remitting experimental autoimmune encephalomyelitis

mGluR
metabotropic glutamate receptor

medicine
Animals
Indoleamine-Pyrrole 2
3
-Dioxygenase

PI3K/AKT/mTOR pathway
ITIM
immunoreceptor tyrosine-based inhibitory motif

medicine.disease
Thiazoles
3-dioxygenase 1
Pyrimidines
030104 developmental biology
Immunology
Cytokine secretion
Indoleamine 2
Zdroj: Neuropharmacology
Popis: Metabotropic glutamate receptor 4 (mGluR4) possesses immune modulatory properties in vivo, such that a positive allosteric modulator (PAM) of the receptor confers protection on mice with relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE). ADX88178 is a newly-developed, one such mGluR4 modulator with high selectivity, potency, and optimized pharmacokinetics. Here we found that application of ADX88178 in the RR-EAE model system converted disease into a form of mild—yet chronic—neuroinflammation that remained stable for over two months after discontinuing drug treatment. In vitro, ADX88178 modulated the cytokine secretion profile of dendritic cells (DCs), increasing production of tolerogenic IL-10 and TGF-β. The in vitro effects required activation of a Gi-independent, alternative signaling pathway that involved phosphatidylinositol-3-kinase (PI3K), Src kinase, and the signaling activity of indoleamine 2,3-dioxygenase 1 (IDO1). A PI3K inhibitor as well as small interfering RNA targeting Ido1—but not pertussis toxin, which affects Gi protein-dependent responses—abrogated the tolerogenic effects of ADX88178-conditioned DCs in vivo. Thus our data indicate that, in DCs, highly selective and potent mGluR4 PAMs such as ADX88178 may activate a Gi-independent, long-lived regulatory pathway that could be therapeutically exploited in chronic autoimmune diseases such as multiple sclerosis.
Highlights • ADX88178, a selective mGluR4 PAM, exerts long-term therapeutic effects in RR-EAE. • ADX88178 activates a noncanonical mGluR4 signaling in DCs. • ADX88178 induces a tolerogenic functional phenotype in DCs via immunoregulatory IDO1. • Highly selective mGluR4 PAMs may represent novel drugs in chronic neuroinflammation.
Databáze: OpenAIRE